Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles

Cancer Gene Therapy

Volumn 10, Issue 12, 2003, Pages 918-925

  Ito, Akira ^a   Matsuoka, Fumiko ^a   Honda, Hiroyuki ^a   Kobayashi, Takeshi ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Cancer immunotherapy; Heat shock proteins; Hyperthermia; Magnetite

Indexed keywords

HEAT SHOCK PROTEIN 70; LIPOSOME; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG SCREENING; GENE THERAPY; HYPERTHERMIC THERAPY; MAGNETIC FIELD; MELANOMA B16; MOUSE; MOUSE STRAIN; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE; TUMOR REGRESSION;

ANIMALS; CELL DIVISION; COMBINED MODALITY THERAPY; ELECTROMAGNETIC FIELDS; FERROSOFERRIC OXIDE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; IRON; LIPOSOMES; MELANOMA; MICE; MICE, INBRED C57BL; NANOTECHNOLOGY; NEOPLASMS, EXPERIMENTAL; OXIDES; PARTICLE SIZE; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANIMALIA;

EID: 0346122775     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700648     Document Type: Article

References (46)

1. Van der Zee J. Heating the patient: a promising approach? Annu Oncol. 2002;13:1173-1184.
2. Moroz P, Jones SK, Gray BN. Magnetically mediated hyperthermia: current status and future directions. Int J Hyperthermia. 2002;18:267-284.
3. Jordan A, Wust P, Fahling H, et al. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia. 1993;9:51-68.
4. Minamimura T, Sato H, Kasaoka S, et al. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol. 2000;16:1153-1158.
5. Shinkai M, Matsui M, Kobayashi T. Heat properties of magnetoliposomes for local hyperthermia. Jpn J Hyperthermic Oncol. 1994;10:168-177.
6. Shinkai M, Yanase M, Honda H, et al. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn J Cancer Res. 1996;87:1179-1183.
7. Yanase M, Shinkai M, Honda H, et al. Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res. 1997;88:630-632.
8. Yanase M, Shinkai M, Honda H, et al. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn J Cancer Res. 1998;89:463-469.
9. Kubista B, Trieb K, Blahovec H, et al. Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis. Anticancer Res, 2002;22:789-792.
10. Mise K, Kan N, Okino T, et al. Effect of heat treatment on tumor cells and antitumor effector cells. Cancer Res. 1990;50:6199-6202.
11. Mondovi B, Santoro AS, Strom R, et al. Increased immunogenicity of Ehrlich ascites cells after heat treatment. Cancer 1972;30:885-888.
12. Ozdemirli M, Akdeniz H, el-Khatib M, et al. A novel cytotoxicity of CD4+ Th1 clones on heat-shocked tumor targets. I. Implications for internal disintegration model for target death and hyperthermia treatment of cancers. J Immunol. 1991;147:4027-4034.
13. Yanase M, Shinkai M, Honda H, et al. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res. 1998;89:775-782.
14. Ito A, Shinkai M, Honda H, et al. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother. 2001;50:515-522.
15. Ito A, Shinkai M, Honda H, et al. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother. 2003;52:80-88.
16. Schlesinger MJ. Heat shock proteins. J Biol Chem. 1990;265:12111-12114.
17. Mosser DD, Caron AW, Bourget L, et al. The chaperone function of hsp 70 is required for protection against stress-induced apoptosis. Mol Cell Biol. 2000;20:7146-7159.
18. Ménoret A, Chandawarkar R. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. Sem Immunol. 1998;25:654-660.
19. Srivastava PK, Ménoret A, Basu S, et al. Heat shock proteins come of age: primitive functions acquired new roles in an adaptive world. Immunity. 1998;8:657-665.
20. Wells AD, Malkovsky M. Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today. 2000;21:129-132.
21. Srivastava PK, Maki RG. Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol. 1991;167:109-123.
22. Srivastava PK, Heike M. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin Immunol. 1993;3:57-64.
23. Srivastava PK, Udono H, Blachere NE, et al. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 1994;39:93-98.
24. Ménoret A, Chaillot D, Callahan M, et al. Hsp70, an immunological actor playing with the intracellular self under oxidative stress. Int J Hyperthermia. 2002;18:490-505.
25. Basu S, Binder R, Suto R, et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NFkB pathway. Int Immunol 2000;12:1539-1546.
26. Parmiani G, Castelli C, Dalerba P, et al. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? J Natl Cancer Inst. 2002;94:805-818.
27. Tamura Y, Peng P, Liu K, et al. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science. 1997;278:117-120.
28. Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med. 1993;178:1391-1396.
29. Ito A, Shinkai M, Honda H, et al. Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther. 2001;8:649-654.
30. Chen CH, Wang TL, Hung CF, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res. 2000;60:1035-1042.
31. Abe M, Hiraoka M, Takahashi M, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer. 1986;58:1589-1595.
32. Suzuki M, Shinkai M, Honda H, et al. Anti-cancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res. 2003;13:129-135.
33. Wells AD, Rai SK, Salvato MS, et al. Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int Immunol. 1998;10:609-617.
34. Todryk S, Melcher AA, Hardwick N, et al. Heat shock protein 70 induced during tumor cell killing induces Thl cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol. 1999;163:1398-1408.
35. Rafiee M, Kanwar JR, Berg RW, et al. Induction of systemic antitumor immunity by gene transfer of mammalian heat shock protein 70.1 into tumors in situ. Cancer Gene Ther. 2001;8:974-981.
36. Ito A, Tanaka K, Kondo K, et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci. 2003;94:308-313.
37. Lindquist S. The heat-shock response. Ann Rev Biochem. 1986;55:1151-1191.
38. Subjeck JR, Sciandra JJ, Chao CF, et al. Heat shock proteins and biological response to hyperthermia. Br J Cancer. 1982;45:127-131.
39. Subjeck JR, Sciandra JJ, Johnson RJ. Heat shock proteins and thermotolerance; a comparison of induction kinetics. Br J Radiol. 1982;55:579-584.
40. Udono H, Srivastava PK. Comparison of tumor-specific immunogenicities of stress-induced protein gp96, hsp90, and hsp70. J Immunol. 1994;152:5398-5403.
41. Wallen ES, Buettner GR, Moseley PL. Oxidants differentially regulate the heat shock response. Int J Hyperthermia. 1997;13:517-524.
42. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991-1045.
43. Breloer M, Marti T, Fleischer B, von Bonin A. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96. Eur J Immunol. 1998;28:1016-1021.
44. Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435-442.
45. Asea A, Kabingu E, Stevenson MA, Calderwood SK. HSP70 peptide-bearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones. 2000;5:425-431.
46. Ito A, Matsuoka F, Honda H, Kobayashi T. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol Immunother. in press.